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Background
Foot ulceration is caused by a variety of factors including
ischemia. GTN is a nitric oxide donor that reliably causes
vasodilation, but its potential to improve local vascular
supply to at-risk feet has received little attention.
When used to supplement standard evidence-based
wound care, transdermal GTN produced rapid ulcer
healing in four cases of non diabetic and diabetic ulcers.
Subsequently, a larger study was conducted to investigate
the effect of using small doses of GTN for therapeutic
neurological and vascula outcomes in people with sub-
normal toe pressures.
Methods
100 participants with toe brachial pressure indices (TBPIs)
< 0.65 were allocated to four groups: two with low doses
of GTN patch medication, a placebo group, and a control
group. GTN doses were 1.25 mg and 2.5 mg applied
constantly over 24 hours and replaced daily. Only the foot
with the lower toe pressure received GTN treatment.
Participants were assessed on both feet monthly for
6 months post intervention. High TBPI variability was
noted in 14 participants, most of whom had unstable
hypertension which was an exclusion criterion. Analysis
proceeded with the remaining 86.
Results
At 1 month post intervention, the TBPIs of the high dose
group were significantly higher than those of the control
group, p = 0.012. At 6 months post intervention, the
TBIs of both the high dose and the low dose groups were
significantly higher than those of the control group, with
p= 0.044 and 0.048 respectively. The placebo group’s
TBIs were also higher than those of the control group,
p= 0.006.
Conclusions
GTN may increase vascular toe perfusion and thereby
assist in wound care and prophylaxis, and might be con-
sidered as an adjunct to other therapy, particularly when
wounds fail to heal. Unexpectedly high placebo group
responses require repeat investigation.
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